Zhejiang Jingxin Pharmaceutical Co Ltd (002020)

Currency in CNY
19.12
+0.63(+3.41%)
Closed·
002020 Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Unusual trading volume
Trading near 52-week High
002020 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.2819.90
52 wk Range
10.5019.90
Key Statistics
Bid/Ask
19.11 / 19.11
Prev. Close
18.49
Open
18.8
Day's Range
18.28-19.9
52 wk Range
10.5-19.9
Volume
63.83M
Average Volume (3m)
23.14M
1-Year Change
76.55%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
002020 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
16.00
Downside
-16.32%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Zhejiang Jingxin Pharmaceutical Co Ltd Company Profile

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactate, levofloxacin hemihydrate, levofloxacin hydrochloride, levofloxacin lactate, enrofloxacin, enrofloxacin hydrochloride, simvastatin, rosuvastatin calcium, pitavastatin calcium, ticagrelor, rivaroxaban, apixaban, cisapride, levetiracetam, brivaracetam, sertraline HCI, rivastigmine bitartrate, pramipexole dihydrochloride, memantine hydrochloride, empagliflozin, dapagliflozin, marbofloxacin, and moxifloxacin. It also provides intermediates; and medical display products, such as diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, ultrasonic medical displays, and other products. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. The company was founded in 1990 and is headquartered in Xinchang, China.

Employees
3869
Market
China

Compare 002020 to Peers and Sector

Metrics to compare
002020
Peers
Sector
Relationship
P/E Ratio
22.4x31.2x−0.5x
PEG Ratio
1.83−0.170.00
Price/Book
2.8x3.2x2.6x
Price / LTM Sales
3.9x4.8x3.3x
Upside (Analyst Target)
−16.3%15.0%43.5%
Fair Value Upside
Unlock4.8%6.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 16.00
(-16.32% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.83%
Dividend Yield
1.83%
Industry Median 1.51%
Annualised payout
0.35
Paid annually
5-Years Growth
+3.71%
Growth Streak

Earnings

Latest Release
Apr 27, 2025
EPS / Forecast
0.20 / --
Revenue / Forecast
956.07M / --
EPS Revisions
Last 90 days

002020 Income Statement

FAQ

What Stock Exchange Does Jingxin Pharm A Trade On?

Jingxin Pharm A is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Jingxin Pharm A?

The stock symbol for Jingxin Pharm A is "002020."

What Is the Jingxin Pharm A Market Cap?

As of today, Jingxin Pharm A market cap is 15.79B.

What Is Jingxin Pharm A's Earnings Per Share (TTM)?

The Jingxin Pharm A EPS (TTM) is 0.83.

When Is the Next Jingxin Pharm A Earnings Date?

Jingxin Pharm A will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is 002020 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Jingxin Pharm A Stock Split?

Jingxin Pharm A has split 4 times.

How Many Employees Does Jingxin Pharm A Have?

Jingxin Pharm A has 3869 employees.

What is the current trading status of Jingxin Pharm A (002020)?

As of 09 Aug 2025, Jingxin Pharm A (002020) is trading at a price of 19.12, with a previous close of 18.49. The stock has fluctuated within a day range of 18.28 to 19.90, while its 52-week range spans from 10.50 to 19.90.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.